Delivery Order SPE2DB22D2206-SPE2DB23FHD44
Award Date 5/12/23
Potential Completion Date 5/15/23
Potential Value $5.8K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $5,429.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 16, 2025. The contract is for the procurement of CATHFLO ACTIVASE 2 MG VIALS, a critical medical commodity supporting the healthcare needs of military personnel, veterans, and other...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,427.39 Firm Fixed Price Delivery Order is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a critical medical product, with a period of performance through December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,705.55, is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a medical product. The contract type is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 8, 2024. This contract award is not designated as a set-aside....
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) to supply CATHFLO ACTIVASE 2 MG VIALS for a total ceiling value of $6,801.93. The contract is a Delivery Order with a Firm Fixed Price pricing type, set to expire on February 3, 2025. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $1,177.99, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of CATHFLO ACTIVASE 2 MG VIALS. The contract has a ceiling value of $22,802.68 and a period of performance through January 7, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,272.76, is a Firm Fixed Price Delivery Order for the supply of CATHFLO ACTIVASE 2 MG VIALS. The contract has an ultimate completion date of March 14, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award and has no major subcontractors mentioned. The contract is not designated...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,902.72 firm-fixed-price delivery order is for the supply of 2 mg vials of CATHFLO ACTIVASE, a medication used to treat certain blood clots. The contract has an ultimate completion date of October 6, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,070.76 delivery order contract is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a critical medical product, to support military healthcare programs. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of CATHFLO ACTIVASE 2 MG VIALS. The contract has a ceiling value of $15,870.89 and an ultimate completion date of March 7, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...